Research progress on financial toxicity of patients with inflammatory bowel disease
10.3760/cma.j.cn115682-20210729-03368
- VernacularTitle:炎症性肠病患者经济毒性的研究进展
- Author:
Mi WANG
1
;
Zheng LIN
;
Meijing ZHOU
;
Zijun GU
;
Caiyun SUN
;
Zhanhui ZHU
;
Junyi GU
Author Information
1. 南京医科大学护理学院，南京 211166
- Keywords:
Review;
Inflammatory bowel disease;
Financial toxicity
- From:
Chinese Journal of Modern Nursing
2022;28(12):1667-1671
- CountryChina
- Language:Chinese
-
Abstract:
Inflammatory bowel disease (IBD) is a chronic non-specific intestinal inflammatory disease of unknown etiology, which is characterized by recurrent episodes and prolonged refractory recovery. Financial toxicity refers to the objective economic burden and subjective economic distress caused by medical expenses caused by the disease to patients. IBD patients show a certain level of financial toxicity due to frequent visits to doctors for a long time. This article reviews the concept of financial toxicity, evaluation tools and the current status of financial toxicity in IBD patients, analyzes the influencing factors of financial toxicity in IBD patients from the aspects of general demography factors, disease and treatment and psychosocial aspects, summarizes and puts forward the countermeasures of toxicity of IBD patients to reduce the economic and the direction of the future study, so as to provide reference for related research.
